Sensitivity and specifity of endosonography in diagnosis of pancreatic head cancer. Clinica general del norte, period 2013-2014

Authors

  • Silvia de Ávila, MD. Universidad Libre
  • Armando Moreno, MD. Universidad Libre
  • Jesús Pérez, MD. Universidad Libre
  • Jorge Bilbao Universidad Libre

Keywords:

Sensitivity, Specificity, Endosonography

Abstract

Objective: To determine the sensitivity and specificity of endosonography in diagnosis of pancreatic head cancer in patients with clinical suspicion of pancreatic cancer served in the Clinica General del Norte, January 2013-December 2014. Materials and methods: Evaluation study using a screening test, Endosonographic a total of 457 procedures were performed; the sample is for convenience in patients endosonography was indicated by clinical suspicion of pancreatic cancer and met the inclusion criteria for a total of 46 patients. Results: Females showed the highest prevalence in the studied sample with 54.3 %, mean age 63.5 ± 3.0 years, 40 cases suggestive of malignancy in endosonography, was correlated with histopathological at 37, and 6 cases of benign pathology findings suggestive of correlated in 1 case. Conclusions: Endosonographic the imaging findings in the diagnosis of pancreatic head cancer, shows a sensitivity of 97.3 %, with a specificity of 62.5 %, based on the pathological-histological report pancreatic tissue (gold standard).

Downloads

Download data is not yet available.

References

1. Lahuerta M, Villata J. Tratamiento paliativo del cáncer de cabeza de páncreas, dos años antes del diagnóstico. An. Med. Interna (Madrid) 2006; (12): 585-7.

2. Hidalgo M. Pancreatic Cancer. N Engl J Med 2010; 362: 1605-17.

3. Argüello P. Cáncer de páncreas. Revisión de Tema. Asociaciones Colombianas de Gastroenterología, Endoscopia digestiva, Coloproctología y Hepatología. 2006; (3): 190-5.

4. Informe Epidemiológico Instituto Nacional de Cancerología, Rev Col de Cancerología 2004; 8: 5-13.

5. Ozaki H, Kinoshita T, Kosuge T, et al. Effectiveness of multimodality treatment for respectable pancreatic cancer. Int J Pancreatol. 1990; 7 (1-3):195-200.

6. Moreno J, Sánchez A, García J, Ramírez G. Avances en cáncer de páncreas, del laboratorio a la clínica. UCLM; 2013.

7. Reddy S, Wolfgang CL, Cameron JL, et al. Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and longterm survival. Ann Surg 2009; 250(2):282-7.

8. Micames C, Jowell PS, White R, Paulson E, Nelson R, Morse M, et al. Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs percuteneous FNA. Gastrointest Endosc. 2003; 58:690-5.

9. Legmann P, Vignaux O, Dousset B, Baraza AJ, Palazzo L, Dumontier I, et al. Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol. 1998; 170:1315-22.

10. Ahmad NA, Lewis JD, Ginsberg GG, Rosato EF, Morris JB, Kochman ML. EUS in preoperative staging of pancreatic cancer. Gastrointest Endosc. 2000 Oct; 52(4):463-8.

11. Maisonneuve P, Lowenfels AB, Bueno de Mesquita HB, et al. Past medical history and pancreatic cancer risk: results from a multicenter case-control study. Ann Epidemiol 2010; 20(2):92-8.

12. AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. Gastroenterology 1999; 117: 1464-84.

13. Erturk SM, Alberich-Bayarri A, Herrmann KA, Marti-Bonmati L, Ros PR. Use of 3.0-TMR imaging for evaluation of the abdomen.

14. Fernández-Esparrach G, Gines A, Pellisé M, et al. Papel de la ultrasonografía endoscópica en el estudio de las colestasis extrahepáticas. Gastroenterol Hepatol 2002; 25: 633-8.

15. Kida M. Pancreatic masses. Gastrointest Endosc 2009; 69: S102-9.

16. Chang KJ. Imaging is overrated: early and frequent use of FNA in pancreatic tumors. Gastrointest Endosc 2009; 69: S157-8.

17. Michaud DS, Giovannucci E, Willet WC, et al. Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA 2001; 286: 921-9.

18. Lodice S, Gandini S, Maisonneuve P, et al. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg 2008; 393(4): 535-45.

19. Mössner J. What is the epidemiologic impact of pancreatic cancer? Clinical Pancreatology for Practising Gastroenterologists and Surgeons. 2011; (41):331-50.

20. Maisonneuve P, Lowenfels AB, Bueno de Mesquita HB, et al. Past medical history and pancreatic cancer risk: results from a multicenter case-control study. Ann Epidemiol 2010; 20(2):92-8.

21. Alguacil J, Kauppinen T, Porta M, et al. Risk of pancreatic cancer and occupational exposures in Spain. PANKRAS II Study Group. Ann Occup Hyg 2000; 44(5): 391-403.

22. Palazzo L. Ecoendoscopia del páncreas. Gastroenterol Hepatol 2002; 25: 26-34

Downloads

Published

2016-06-01

How to Cite

Sensitivity and specifity of endosonography in diagnosis of pancreatic head cancer. Clinica general del norte, period 2013-2014. (2016). Biociencias, 11(1), 49-55. https://revistas.unilibre.edu.co/index.php/biociencias/article/view/2870